II 

Calendar No. 122 

112TH CONGRESS 

1ST SESSION S. 605 

To amend the Controlled Substances Act to place synthetic drugs in Schedule 

I. 

IN THE SENATE OF THE UNITED STATES 

MARCH 17, 2011 

Mr. GRASSLEY (for himself, Mrs. FEINSTEIN, Mr. HATCH, Ms. KLOBUCHAR, 

Mr. MANCHIN, Mrs. HAGAN, Mr. WHITEHOUSE, Mr. WYDEN, Mr. CASEY, 

Mr. BLUMENTHAL, and Mr. SCHUMER) introduced the following bill; 

which was read twice and referred to the Committee on the Judiciary 

JULY 29, 2011 

Reported by Mr. LEAHY, without amendment 

A BILL 

To amend the Controlled Substances Act to place synthetic 

drugs in Schedule I. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Dangerous Synthetic 

5 Drug Control Act of 2011’’ or the ‘‘David Mitchell Rozga 

6 Act’’. 


smartinez on DSK6TPTVN1PROD with BILLS
2 

•S 605 RS

1 SEC. 2. ADDITION OF CANNABIMIMETIC AGENTS TO SCHED2 ULE I OF THE CONTROLLED SUBSTANCES 

3 ACT. 

4 Schedule I, as set forth in section 202(c) of the Con5 trolled Substances Act (21 U.S.C. 812(c)) is amended by 

6 adding at the end the following: 

7 ‘‘(d)(1) Unless specifically exempted or unless listed 

8 in another schedule, any material, compound, mixture, or 

9 preparation which contains any quantity of cannabimimet10 ic agents, their salts, isomers, and salts of isomers when11 ever the existence of such salts, isomers, and salts of iso12 mers is possible within the specific chemical designation. 

13 ‘‘(2) In paragraph (1), the term ‘cannabimimetic 

14 agents’— 

15 ‘‘(A) means any substance that is a cannabinoid 

16 receptor type 1 (CB1 receptor) agonist as dem17 onstrated by binding studies and functional assays 

18 within the following structural classes: 

19 ‘‘(i) 2-(3-hydroxycyclohexyl)phenol with 

20 substitution at the 5-position of the phenolic 

21 ring by alkyl or alkenyl, whether or not sub22 stituted on the cyclohexyl ring to any extent. 

23 ‘‘(ii) 3-(1-naphthoyl)indole or 3-(1-naph24 thyl)indole by substitution at the nitrogen atom 

25 of the indole ring, whether or not further sub26 stituted on the indole ring to any extent, whethVerDate Mar 15 2010 00:24 Jul 30, 2011 Jkt 099200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\S605.RS S605

smartinez on DSK6TPTVN1PROD with BILLS
3 

•S 605 RS

1 er or not substituted on the naphthoyl or 

2 naphthyl ring to any extent. 

3 ‘‘(iii) 3-(1-naphthoyl)pyrrole by substi4 tution at the nitrogen atom of the pyrrole ring, 

5 whether or not further substituted in the indole 

6 ring to any extent, whether or not substituted 

7 on the naphthoyl ring to any extent. 

8 ‘‘(iv) 1-(1-naphthylmethyl)indene by substi9 tution of the 3-position of the indene ring, 

10 whether or not further substituted in the indene 

11 ring to any extent, whether or not substituted 

12 on the naphthyl ring to any extent. 

13 ‘‘(v) 3-phenylacetylindole or 3-benzoylin14 dole by substitution at the nitrogen atom of the 

15 indole ring, whether or not further substituted 

16 in the indole ring to any extent, whether or not 

17 substituted on the phenyl ring to any extent.; 

18 and 

19 ‘‘(B) includes— 

20 ‘‘(i) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3- 

21 hydroxycyclohexyl]-phenol (CP–47,497); 

22 ‘‘(ii) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3- 

23 hydroxycyclohexyl]-phenol (cannabicyclohexanol 

24 or CP–47,497 C8–homolog); 


smartinez on DSK6TPTVN1PROD with BILLS
4 

•S 605 RS

1 ‘‘(iii) 1-pentyl-3-(1-naphthoyl)indole 

2 (JWH–018 and AM678); 

3 ‘‘(iv) 1-butyl-3-(1-naphthoyl)indole (JWH– 

4 073); 

5 ‘‘(v) 1-hexyl-3-(1-naphthoyl)indole (JWH– 

6 019); 

7 ‘‘(vi) 1-[2-(4-morpholinyl)ethyl]-3-(1-naph8 thoyl)indole (JWH–200); 

9 ‘‘(vii) 1-pentyl-3-(2-methoxyphenyl10 acetyl)indole (JWH–250); 

11 ‘‘(viii) 1-pentyl-3-[1-(4-methoxynaph12 thoyl)]indole (JWH–081); 

13 ‘‘(ix) 1-pentyl-3-(4-methyl-1-naph14 thoyl)indole (JWH–122); 

15 ‘‘(x) 1-pentyl-3-(4-chloro-1-naph16 thoyl)indole (JWH–398); 

17 ‘‘(xi) 1-(5-fluoropentyl)-3-(1-naph18 thoyl)indole (AM2201); 

19 ‘‘(xii) 1-(5-fluoropentyl)-3-(2-iodoben20 zoyl)indole (AM694); 

21 ‘‘(xiii) 1-pentyl-3-[(4-methoxy-ben22 zoyl]indole (SR–19 and RCS–4); 

23 ‘‘(xiv) 1-cyclohexylethyl-3-(2-methoxy24 phenylacetyl)indole (SR–18 and RCS–8); and 


smartinez on DSK6TPTVN1PROD with BILLS
5 

•S 605 RS

1 ‘‘(xv) 1-pentyl-3-(2-chlorophenylace2 tyl)indole (JWH–203).’’. 

3 SEC. 3. TEMPORARY SCHEDULING TO AVOID IMMINENT 

4 HAZARDS TO PUBLIC SAFETY EXPANSION. 

5 Section 201(h)(2) of the Controlled Substances Act 

6 (21 U.S.C. 811(h)(2)) is amended— 

7 (1) by striking ‘‘one year’’ and inserting ‘‘2 

8 years’’; and 

9 (2) by striking ‘‘six months’’ and inserting ‘‘1 

10 year’’. 


smartinez on DSK6TPTVN1PROD with BILLS
Calendar No. 122 

112TH CONGRESS 

1ST SESSION S. 605 

A BILL 

To amend the Controlled Substances Act to place 

synthetic drugs in Schedule I. 

JULY 29, 2011 

Reported without amendment 


smartinez on DSK6TPTVN1PROD with BILLS